x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
Delaware
|
39-0394230
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
Three Months Ended
|
Six Months Ended
|
||||||||||||
June 30
|
June 30
|
||||||||||||
(Millions
of dollars, except per share amounts)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Net
Sales
|
$
|
4,502.0
|
$
|
4,161.4
|
$
|
8,887.3
|
$
|
8,229.3
|
|||||
Cost
of products
sold
|
3,056.0
|
2,873.8
|
6,089.0
|
5,788.6
|
|||||||||
Gross
Profit
|
1,446.0
|
1,287.6
|
2,798.3
|
2,440.7
|
|||||||||
Marketing,
research and general
expenses
|
797.6
|
741.9
|
1,530.2
|
1,454.4
|
|||||||||
Other
(income) and expense,
net
|
(.3
|
)
|
1.6
|
3.3
|
21.8
|
||||||||
Operating
Profit
|
648.7
|
544.1
|
1,264.8
|
964.5
|
|||||||||
Nonoperating
expense
|
(47.5
|
)
|
(7.6
|
)
|
(75.1
|
)
|
(23.4
|
)
|
|||||
Interest
income
|
7.4
|
6.6
|
14.0
|
13.0
|
|||||||||
Interest
expense
|
(51.9
|
)
|
(55.1
|
)
|
(102.8
|
)
|
(109.4
|
)
|
|||||
Income
Before Income Taxes and
|
|||||||||||||
Equity
Interests
|
556.7
|
488.0
|
1,100.9
|
844.7
|
|||||||||
Provision
for income
taxes
|
(111.5
|
)
|
(131.0
|
)
|
(223.6
|
)
|
(230.3
|
)
|
|||||
Income
Before Equity Interests
|
445.2
|
357.0
|
877.3
|
614.4
|
|||||||||
Share
of net income of equity
companies
|
42.8
|
42.9
|
87.8
|
81.9
|
|||||||||
Minority
owners’ share of
subsidiaries’ net
|
|||||||||||||
income
|
(26.2
|
)
|
(22.3
|
)
|
(51.3
|
)
|
(43.6
|
)
|
|||||
Net
Income
|
$
|
461.8
|
$
|
377.6
|
$
|
913.8
|
$
|
652.7
|
|||||
Per
Share Basis:
|
|||||||||||||
Net
Income
|
|||||||||||||
Basic
|
$
|
1.01
|
$
|
.82
|
$
|
2.01
|
$
|
1.42
|
|||||
Diluted
|
$
|
1.00
|
$
|
.82
|
$
|
1.99
|
$
|
1.41
|
|||||
Cash
Dividends
Declared
|
$
|
.53
|
$
|
.49
|
$
|
1.06
|
$
|
.98
|
June 30,
|
December 31,
|
||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||
ASSETS
|
|||||||
Current
Assets
|
|||||||
Cash
and cash
equivalents
|
$
|
457.0
|
$
|
360.8
|
|||
Accounts
receivable,
net
|
2,401.6
|
2,336.7
|
|||||
Inventories
|
2,243.5
|
2,004.5
|
|||||
Other
current
assets
|
552.8
|
567.7
|
|||||
Total
Current
Assets
|
5,654.9
|
5,269.7
|
|||||
Property
|
15,892.3
|
15,404.9
|
|||||
Less
accumulated
depreciation
|
8,021.8
|
7,720.1
|
|||||
Net
Property
|
7,870.5
|
7,684.8
|
|||||
Investments
in Equity Companies
|
445.1
|
392.9
|
|||||
Goodwill
|
2,955.7
|
2,860.5
|
|||||
Other
Assets
|
920.4
|
859.1
|
|||||
$
|
17,846.6
|
$
|
17,067.0
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
Liabilities
|
|||||||
Debt
payable within one
year
|
$
|
1,335.1
|
$
|
1,326.4
|
|||
Accounts
payable
|
1,711.0
|
1,530.8
|
|||||
Accrued
expenses
|
1,562.9
|
1,603.8
|
|||||
Other
current
liabilities
|
310.3
|
554.8
|
|||||
Total
Current
Liabilities
|
4,919.3
|
5,015.8
|
|||||
Long-Term
Debt
|
2,278.4
|
2,276.0
|
|||||
Noncurrent
Employee Benefits
|
1,864.1
|
1,887.6
|
|||||
Deferred
Income Taxes
|
231.9
|
391.1
|
|||||
Other
Liabilities
|
617.4
|
183.1
|
|||||
Minority
Owners’ Interests in Subsidiaries
|
428.5
|
422.6
|
|||||
Preferred
Securities of Subsidiary
|
811.9
|
793.4
|
|||||
Stockholders’
Equity
|
6,695.1
|
6,097.4
|
|||||
$
|
17,846.6
|
$
|
17,067.0
|
Six Months
|
|||||||
Ended June 30
|
|||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||
Operating
Activities
|
|||||||
Net
income
|
$
|
913.8
|
$
|
652.7
|
|||
Depreciation
and
amortization
|
412.9
|
499.6
|
|||||
Stock-based
compensation
|
37.6
|
36.1
|
|||||
Changes
in operating working
capital
|
(100.5
|
)
|
(71.9
|
)
|
|||
Deferred
income tax
provision
|
(90.2
|
)
|
(99.8
|
)
|
|||
Net
losses on asset
dispositions
|
14.7
|
74.0
|
|||||
Equity
companies’ earnings in
excess of dividends paid
|
(55.5
|
)
|
(48.1
|
)
|
|||
Minority
owners’ share of
subsidiaries’ net income
|
51.3
|
43.6
|
|||||
Postretirement
benefits
|
.5
|
30.7
|
|||||
Other
|
(8.6
|
)
|
1.8
|
||||
Cash
Provided by
Operations
|
1,176.0
|
1,118.7
|
|||||
Investing
Activities
|
|||||||
Capital
spending
|
(544.0
|
)
|
(398.6
|
)
|
|||
Acquisition
of businesses, net of
cash acquired
|
(15.7
|
)
|
-
|
||||
Proceeds
from sales of
investments
|
12.4
|
17.4
|
|||||
Proceeds
from dispositions of
property
|
60.0
|
24.7
|
|||||
Net
decrease in time
deposits
|
17.9
|
17.0
|
|||||
Investments
in marketable
securities
|
(4.1
|
)
|
(18.7
|
)
|
|||
Other
|
(24.9
|
)
|
(7.1
|
)
|
|||
Cash
Used for
Investing
|
(498.4
|
)
|
(365.3
|
)
|
|||
Financing
Activities
|
|||||||
Cash
dividends
paid
|
(465.8
|
)
|
(434.5
|
)
|
|||
Net
increase (decrease) in
short-term debt
|
8.2
|
(111.5
|
)
|
||||
Proceeds
from issuance of
long-term debt
|
27.4
|
31.4
|
|||||
Repayments
of long-term
debt
|
(35.7
|
)
|
(62.8
|
)
|
|||
Proceeds
from exercise of stock
options
|
213.5
|
106.1
|
|||||
Acquisitions
of common stock for
the treasury
|
(315.5
|
)
|
(301.1
|
)
|
|||
Other
|
(16.7
|
)
|
(11.2
|
)
|
|||
Cash
Used for
Financing
|
(584.6
|
)
|
(783.6
|
)
|
|||
Effect
of Exchange Rate Changes on Cash and Cash Equivalents
|
3.2
|
3.6
|
|||||
Increase
(decrease) in Cash and Cash Equivalents
|
96.2
|
(26.6
|
)
|
||||
Cash
and Cash Equivalents, beginning of year
|
360.8
|
364.0
|
|||||
Cash
and Cash Equivalents, end of period
|
$
|
457.0
|
$
|
337.4
|
Jurisdiction
|
Years
|
United
States
|
2004
to 2006
|
United
Kingdom
|
1999
to 2006
|
Canada
|
2003
to 2006
|
Korea
|
2004
to 2006
|
Australia
|
2002
to 2006
|
Three
Months
|
Six
Months
|
|||||||||||
Ended
June 30
|
Ended
June 30
|
|||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
||||||||
Noncash
charges
|
$
|
20.7
|
$
|
59.3
|
$
|
44.6
|
$
|
183.4
|
||||
Charges
(credits) for workforce reductions
|
(10.6
|
)
|
18.0
|
(6.0
|
)
|
95.0
|
||||||
Other
cash charges
|
6.9
|
10.9
|
15.3
|
18.1
|
||||||||
Charges
for special pension and other benefits
|
.8
|
1.2
|
4.5
|
1.5
|
||||||||
Total
pretax charges
|
$
|
17.8
|
$
|
89.4
|
$
|
58.4
|
$
|
298.0
|
Three
Months
|
Six
Months
|
|||||||||||
Ended
June 30
|
Ended
June 30
|
|||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
||||||||
Incremental
depreciation and amortization
|
$
|
19.3
|
$
|
56.2
|
$
|
49.7
|
$
|
134.4
|
||||
Asset
write-offs
|
1.4
|
2.5
|
4.7
|
37.7
|
||||||||
(Gain)
loss on asset dispositions
|
-
|
.6
|
(9.8
|
)
|
11.3
|
|||||||
Noncash
charges
|
$
|
20.7
|
$
|
59.3
|
$
|
44.6
|
$
|
183.4
|
(Millions
of dollars)
|
2007
|
2006
|
|||||
Accrued
expenses – beginning of the year
|
$
|
111.2
|
$
|
28.2
|
|||
Charges
(credits) for workforce reductions
|
(6.0
|
)
|
95.0
|
||||
Other
cash charges
|
15.3
|
18.1
|
|||||
Cash
payments
|
(63.0
|
)
|
(81.7
|
)
|
|||
Currency
|
2.3
|
.1
|
|||||
Accrued
expenses at June 30
|
$
|
59.8
|
$
|
59.7
|
Three Months
|
Six Months
|
||||||||||||
Ended June 30
|
Ended June
30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Cost
of products sold
|
$
|
10.7
|
$
|
66.4
|
$
|
52.5
|
$
|
222.1
|
|||||
Marketing,
research and general expenses
|
7.1
|
23.0
|
15.2
|
65.0
|
|||||||||
Other
(income) and expense, net
|
-
|
-
|
(9.3
|
)
|
10.9
|
||||||||
Pretax
charges
|
17.8
|
89.4
|
58.4
|
298.0
|
|||||||||
Provision
for income taxes
|
(7.9
|
)
|
(29.3
|
)
|
(33.5
|
)
|
(82.7
|
)
|
|||||
Minority
owners’ share of subsidiaries’ net income
|
(.1
|
)
|
.2
|
(.1
|
)
|
(1.4
|
)
|
||||||
Total
charges
|
$
|
9.8
|
$
|
60.3
|
$
|
24.8
|
$
|
213.9
|
2007
|
||||||||||||||
(Millions
of dollars)
|
North
America
|
Europe
|
Other
|
Total
|
||||||||||
Incremental
depreciation
|
$
|
13.4
|
$
|
6.7
|
$
|
(.8
|
)
|
$
|
19.3
|
|||||
Asset
write-offs
|
1.2
|
(.2
|
)
|
.4
|
1.4
|
|||||||||
Charges
(credits) for workforce reductions and
|
||||||||||||||
special
pension and other
benefits
|
5.3
|
(18.7
|
)
|
3.6
|
(9.8
|
)
|
||||||||
Loss on asset disposals and other charges
|
4.8
|
1.2
|
.9
|
6.9
|
||||||||||
Total
charges
(credits)
|
$
|
24.7
|
$
|
(11.0
|
)
|
$
|
4.1
|
$
|
17.8
|
2006
|
||||||||||||||
(Millions
of dollars)
|
North
America
|
Europe
|
Other
|
Total
|
||||||||||
Incremental
depreciation and amortization
|
$
|
39.1
|
$
|
10.8
|
$
|
6.3
|
$
|
56.2
|
||||||
Asset
write-offs
|
.9
|
1.6
|
-
|
2.5
|
||||||||||
Charges
for workforce reductions and
|
||||||||||||||
special
pension and other
benefits
|
17.5
|
1.3
|
.4
|
19.2
|
||||||||||
Loss
on asset disposals and other charges
|
10.1
|
1.1
|
.3
|
11.5
|
||||||||||
Total
charges
|
$
|
67.6
|
$
|
14.8
|
$
|
7.0
|
$
|
89.4
|
2007
|
||||||||||||||
(Millions
of dollars)
|
North
America
|
Europe
|
Other
|
Total
|
||||||||||
Incremental
depreciation
|
$
|
29.3
|
$
|
19.7
|
$
|
.7
|
$
|
49.7
|
||||||
Asset
write-offs
|
3.0
|
1.2
|
.5
|
4.7
|
||||||||||
Charges
(credits) for workforce reductions and
|
||||||||||||||
special
pension and other
benefits
|
11.6
|
(17.0
|
)
|
3.9
|
(1.5
|
)
|
||||||||
Loss on asset disposals and other charges
|
8.8
|
5.0
|
1.0
|
14.8
|
||||||||||
Total
charges
|
$
|
52.7
|
$
|
8.9
|
$
|
6.1
|
$
|
67.7
|
2006
|
||||||||||||||
(Millions
of dollars)
|
North
America
|
Europe
|
Other
|
Total
|
||||||||||
Incremental
depreciation and amortization
|
$
|
77.6
|
$
|
38.4
|
$
|
18.4
|
$
|
134.4
|
||||||
Asset
write-offs
|
23.5
|
14.0
|
.2
|
37.7
|
||||||||||
Charges
for workforce reductions and
|
||||||||||||||
special
pension and other
benefits
|
25.4
|
65.4
|
5.7
|
96.5
|
||||||||||
Loss
on asset disposals and other charges
|
18.0
|
.3
|
.2
|
18.5
|
||||||||||
Total
charges
|
$
|
144.5
|
$
|
118.1
|
$
|
24.5
|
$
|
287.1
|
June 30,
|
December 31,
|
||||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||||
At lower of cost on the First-In, First-Out (FIFO) method or market:
|
|||||||||
Raw
materials
|
$
|
425.6
|
$
|
398.3
|
|||||
Work
in process
|
315.9
|
298.6
|
|||||||
Finished
goods
|
1,461.8
|
1,263.4
|
|||||||
Supplies
and other
|
256.6
|
242.6
|
|||||||
2,459.9
|
2,202.9
|
||||||||
Excess
of FIFO cost over Last-In, First-Out (LIFO) cost
|
(216.4
|
)
|
(198.4
|
)
|
|||||
Total
|
$
|
2,243.5
|
$
|
2,004.5
|
Three
Months Ended June 30
|
|||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||||||||
Nonoperating
expense
|
$
|
(47.5
|
)
|
$
|
(7.6
|
)
|
|||||||
Tax
credits
|
$
|
43.9
|
$
|
6.6
|
|||||||||
Tax
benefit of nonoperating expense
|
15.6
|
59.5
|
2.6
|
9.2
|
|||||||||
Net
synthetic fuel benefit
|
$
|
12.0
|
$
|
1.6
|
|||||||||
Per
share basis – diluted
|
$
|
.03
|
$
|
-
|
Six
Months Ended June 30
|
|||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||||||||
Nonoperating
expense
|
$
|
(75.1
|
)
|
$
|
(23.4
|
)
|
|||||||
Tax
credits
|
$
|
69.5
|
$
|
20.4
|
|||||||||
Tax
benefit of nonoperating expense
|
24.7
|
94.2
|
8.3
|
28.7
|
|||||||||
Net
synthetic fuel benefit
|
$
|
19.1
|
$
|
5.3
|
|||||||||
Per
share basis – diluted
|
$
|
.04
|
$
|
.01
|
Defined
|
Other Postretirement
|
|||||||||||
Benefit Plans
|
Benefit Plans
|
|||||||||||
Three Months Ended June 30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
||||||||
Service
cost
|
$
|
20.2
|
$
|
21.8
|
$
|
3.2
|
$
|
3.3
|
||||
Interest
cost
|
77.9
|
73.8
|
12.9
|
11.4
|
||||||||
Expected
return on plan assets
|
(92.8
|
)
|
(84.5
|
)
|
-
|
-
|
||||||
Recognized
net actuarial loss
|
18.6
|
25.0
|
1.8
|
.7
|
||||||||
Other
|
2.8
|
3.1
|
.8
|
.9
|
||||||||
Net
periodic benefit cost
|
$
|
26.7
|
$
|
39.2
|
$
|
18.7
|
$
|
16.3
|
Defined
|
Other Postretirement
|
|||||||||||
Benefit Plans
|
Benefit Plans
|
|||||||||||
Six Months Ended June 30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
||||||||
Service
cost
|
$
|
41.6
|
$
|
43.7
|
$
|
6.6
|
$
|
7.5
|
||||
Interest
cost
|
156.6
|
148.2
|
25.0
|
23.5
|
||||||||
Expected
return on plan assets
|
(184.9
|
)
|
(167.8
|
)
|
-
|
-
|
||||||
Recognized
net actuarial loss
|
37.9
|
50.2
|
2.6
|
2.0
|
||||||||
Other
|
7.8
|
5.3
|
1.6
|
1.7
|
||||||||
Net
periodic benefit cost
|
$
|
59.0
|
$
|
79.6
|
$
|
35.8
|
$
|
34.7
|
|
Average Common Shares Outstanding
|
||||||||
Three Months
|
Six Months
|
||||||||
Ended June 30
|
Ended June 30
|
||||||||
(Millions
of shares)
|
2007
|
2006
|
2007
|
2006
|
|||||
Basic
|
455.6
|
459.0
|
455.7
|
459.7
|
|||||
Dilutive
effect of stock options
|
2.7
|
.5
|
2.7
|
.7
|
|||||
Dilutive
effect of restricted share and restricted share unit
|
|||||||||
awards
|
1.3
|
1.3
|
1.4
|
1.0
|
|||||
Diluted
|
459.6
|
460.8
|
459.8
|
461.4
|
Six Months
|
|||||||
Ended June 30
|
|||||||
(Millions
of dollars)
|
2007
|
2006
|
|||||
Net
income
|
$
|
913.8
|
$
|
652.7
|
|||
Unrealized
currency translation adjustments
|
182.5
|
232.9
|
|||||
Employee
postretirement benefits, net
|
55.0
|
-
|
|||||
Deferred
gains (losses) on cash flow hedges, net of tax
|
5.4
|
(8.1
|
)
|
||||
Unrealized
holding losses on marketable securities
|
(.1
|
)
|
(.1
|
)
|
|||
Comprehensive
income
|
$
|
1,156.6
|
$
|
877.4
|
·
|
The
Personal Care segment manufactures and markets disposable diapers,
training and youth pants and swimpants; baby wipes; feminine and
incontinence care products; and related products. Products in
this segment are primarily for household use and are sold under
a variety
of brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites,
Kotex, Lightdays, Depend, Poise and other brand
names.
|
·
|
The
Consumer Tissue segment manufactures and markets facial and bathroom
tissue, paper towels, napkins and related products for household
use. Products in this segment are sold under the Kleenex,
Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other
brand
names.
|
·
|
The
K-C Professional & Other segment manufactures and markets facial and
bathroom tissue, paper towels, napkins, wipers and a range of safety
products for the away-from-home marketplace. Products in this
segment are sold under the Kimberly-Clark, Kleenex, Scott, WypAll,
Kimtech, Kleenguard and Kimcare brand
names.
|
·
|
The
Health Care segment manufactures and markets disposable health
care
products such as surgical gowns, drapes, infection control products,
sterilization wrap, face masks, exam gloves, respiratory products
and
other disposable medical products. Products in this segment are
sold under the Kimberly-Clark, Ballard and other brand
names.
|
Three Months
|
Six Months
|
||||||||||||
Ended June 30
|
Ended June
30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
NET
SALES:
|
|||||||||||||
Personal
Care
|
$
|
1,881.5
|
$
|
1,715.1
|
$
|
3,679.1
|
$
|
3,340.1
|
|||||
Consumer
Tissue
|
1,568.6
|
1,434.4
|
3,161.7
|
2,931.6
|
|||||||||
K-C
Professional & Other
|
763.0
|
704.0
|
1,460.4
|
1,356.8
|
|||||||||
Health
Care
|
296.7
|
317.8
|
599.4
|
618.3
|
|||||||||
Corporate
& Other
|
9.0
|
7.7
|
17.0
|
16.7
|
|||||||||
Intersegment
sales
|
(16.8
|
)
|
(17.6
|
)
|
(30.3
|
)
|
(34.2
|
)
|
|||||
Consolidated
|
$
|
4,502.0
|
$
|
4,161.4
|
$
|
8,887.3
|
$
|
8,229.3
|
Three Months
|
Six Months
|
||||||||||||
Ended June 30
|
Ended June 30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
OPERATING PROFIT (reconciled to income before
|
|||||||||||||
income taxes):
|
|||||||||||||
Personal
Care
|
$
|
393.2
|
$
|
328.4
|
$
|
740.4
|
$
|
628.6
|
|||||
Consumer
Tissue
|
168.9
|
177.6
|
376.0
|
386.6
|
|||||||||
K-C
Professional & Other
|
119.9
|
113.9
|
228.6
|
218.4
|
|||||||||
Health
Care
|
52.0
|
58.3
|
107.6
|
109.6
|
|||||||||
Other
income and (expense), net
|
.3
|
(1.6
|
)
|
(3.3
|
)
|
(21.8
|
)
|
||||||
Corporate
& Other
|
(85.6
|
)
|
(132.5
|
)
|
(184.5
|
)
|
(356.9
|
)
|
|||||
Total
Operating Profit
|
648.7
|
544.1
|
1,264.8
|
964.5
|
|||||||||
Nonoperating
expense
|
(47.5
|
)
|
(7.6
|
)
|
(75.1
|
)
|
(23.4
|
)
|
|||||
Interest
income
|
7.4
|
6.6
|
14.0
|
13.0
|
|||||||||
Interest
expense
|
(51.9
|
)
|
(55.1
|
)
|
(102.8
|
)
|
(109.4
|
)
|
|||||
Income
Before Income Taxes
|
$
|
556.7
|
$
|
488.0
|
$
|
1,100.9
|
$
|
844.7
|
Note:
|
Other
income and (expense), net and Corporate & Other include the following
amounts of pretax charges for the
strategic cost reductions. In 2007, Corporate &
Other also includes the related implementation
costs.
|
Three Months
|
Six Months
|
||||||||||||
Ended June 30
|
Ended June
30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Other
income and (expense), net
|
$
|
-
|
$
|
-
|
$
|
9.3
|
$
|
(10.9
|
)
|
||||
Corporate
and Other
|
(28.8
|
)
|
(89.4
|
)
|
(90.9
|
)
|
(287.1
|
)
|
Three Months
|
Six Months
|
||||||||||||
Ended June 30
|
Ended June
30
|
||||||||||||
(Millions
of dollars)
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Personal
Care
|
$
|
22.2
|
$
|
56.3
|
$
|
50.2
|
$
|
171.9
|
|||||
Consumer
Tissue
|
(12.9
|
)
|
16.8
|
3.0
|
79.8
|
||||||||
K-C
Professional & Other
|
4.0
|
4.0
|
6.6
|
10.7
|
|||||||||
Health
Care
|
4.5
|
12.3
|
7.9
|
24.7
|
|||||||||
Total
|
$
|
17.8
|
$
|
89.4
|
$
|
67.7
|
$
|
287.1
|
·
|
Overview
of Second Quarter 2007 Results
|
·
|
Business
Segments
|
·
|
Results
of Operations and Related
Information
|
·
|
Liquidity
and Capital Resources
|
·
|
New
Accounting Standard
|
·
|
Environmental
Matters
|
·
|
Business
Outlook
|
·
|
Net
sales increased 8.2 percent compared with last
year.
|
·
|
Operating
profit and net income increased by 19.2 percent and 22.3 percent,
respectively, compared with last
year.
|
·
|
Cash
provided by operations was $651.5
million.
|
Net
Sales
|
2007
|
2006
|
||||
Personal
Care
|
$
|
1,881.5
|
$
|
1,715.1
|
||
Consumer
Tissue
|
1,568.6
|
1,434.4
|
||||
K-C
Professional & Other
|
763.0
|
704.0
|
||||
Health
Care
|
296.7
|
317.8
|
||||
Corporate
& Other
|
9.0
|
7.7
|
||||
Intersegment
sales
|
(16.8
|
)
|
(17.6
|
)
|
||
Consolidated
|
$
|
4,502.0
|
$
|
4,161.4
|
Percent Change in Net Sales Versus Prior Year
|
|||||||||||||||
Changes Due To
|
|||||||||||||||
Total
|
Volume
|
Net
|
|||||||||||||
Change
|
Growth
|
Price
|
Currency
|
Other
|
|||||||||||
Consolidated
|
8.2
|
4
|
1
|
3
|
-
|
||||||||||
Personal
Care
|
9.7
|
6
|
-
|
3
|
1
|
||||||||||
Consumer
Tissue
|
9.4
|
3
|
2
|
4
|
-
|
||||||||||
K-C
Professional & Other
|
8.4
|
4
|
1
|
3
|
-
|
||||||||||
Health
Care
|
(6.6
|
)
|
(8
|
)
|
-
|
1
|
-
|
·
|
Net
sales of personal care products climbed 9.7 percent in the second
quarter, driven primarily by a 6 percent increase in sales volumes
and currency benefits of 3 percent. Net selling prices and
product mix both improved slightly compared with the prior
year.
|
·
|
Net
sales of consumer tissue products improved 9.4 percent versus the
second
quarter of 2006, as sales volumes and net selling prices moved
higher by
approximately 3 percent and 2 percent, respectively, while
changes in foreign currency rates contributed an additional
4 percent.
|
·
|
Net
sales of K-C Professional & Other products advanced 8.4 percent
compared with the year-ago quarter. Sales volumes increased
more than 4 percent, net selling prices were up about 1 percent and
favorable currency effects benefited sales by 3 percent. As a
result of its focused strategy to expand in the profitable, growing
workplace and safety markets, global sales of K-C Professional’s (“KCP”)
differentiated apparel, glove and wiper products continued to experience
strong growth. Meanwhile, sales of washroom products posted
solid gains in North America and Europe. In addition, KCP
continued to capitalize on opportunities in higher growth international
markets, generating double-digit net sales increases in the second
quarter
in both Asia and Latin America.
|
·
|
Net
sales of health care products were down 6.6 percent in the second
quarter. Sales volumes were approximately
8 percent lower, partially offset by currency benefits
of 1 percent. The decrease in sales volumes was primarily
attributable to the Corporation’s decision in the second half of last year
to exit the latex exam glove business, along with very strong sales
of
face masks in the year-ago quarter primarily related to avian flu
preparedness. In the exam glove category, the Corporation has
successfully transitioned many customers and users from latex to
its
higher-margin, better performing nitrile products over the last
nine
months. The growth in sales volumes of nitrile exam gloves,
although rapid, has not fully compensated for the drop-off in sales
of
latex gloves, due in part to supply constraints that have recently
been
resolved as new manufacturing capacity has come on line. As a
result, overall sales volumes of exam gloves declined approximately
30 percent in the second quarter. In other areas of the
business, second quarter sales volumes of medical devices, particularly
Ballard respiratory catheters, generated solid
improvement.
|
Net
Sales
|
2007
|
2006
|
||||
North
America
|
$
|
2,533.2
|
$
|
2,427.9
|
||
Outside
North America
|
2,138.5
|
1,872.8
|
||||
Intergeographic
sales
|
(169.7
|
)
|
(139.3
|
)
|
||
Consolidated
|
$
|
4,502.0
|
$
|
4,161.4
|
·
|
Net
sales in North America increased 4.3 percent primarily due to higher
sales
volumes for personal care, family care and K-C Professional & Other
products.
|
·
|
Net
sales outside North America increased 14.2 percent primarily due
to higher
personal care sales volumes, increased net selling prices for consumer
tissue and favorable currency effects in
Europe.
|
Operating
Profit
|
2007
|
2006
|
||||
Personal
Care
|
$
|
393.2
|
$
|
328.4
|
||
Consumer
Tissue
|
168.9
|
177.6
|
||||
K-C
Professional & Other
|
119.9
|
113.9
|
||||
Health
Care
|
52.0
|
58.3
|
||||
Other
income and (expense), net
|
.3
|
(1.6
|
)
|
|||
Corporate
& Other
|
(85.6
|
)
|
(132.5
|
)
|
||
Consolidated
|
$
|
648.7
|
$
|
544.1
|
Percentage Change in Operating Profit Versus Prior Year
|
|||||||||||||||||||||||||||
Changes Due To
|
|||||||||||||||||||||||||||
Raw
|
Energy and
|
||||||||||||||||||||||||||
Total
|
Net
|
Materials
|
Distribution
|
||||||||||||||||||||||||
Change
|
Volume
|
Price
|
Cost
|
Expense
|
Currency
|
Other
(a)
|
|||||||||||||||||||||
Consolidated
|
19.2
|
13
|
9
|
(15
|
)
|
(3
|
)
|
4
|
11
|
(b)
|
|||||||||||||||||
Personal
Care
|
19.7
|
15
|
3
|
(6
|
)
|
(1
|
)
|
2
|
7
|
||||||||||||||||||
Consumer
Tissue
|
(4.9
|
)
|
7
|
17
|
(19
|
)
|
(5
|
)
|
3
|
(8
|
)
|
||||||||||||||||
K-C
Professional &
Other
|
5.3
|
9
|
7
|
(19
|
)
|
(2
|
)
|
1
|
9
|
||||||||||||||||||
Health
Care
|
(10.8
|
)
|
(4
|
)
|
2
|
(8
|
)
|
(6
|
)
|
5
|
-
|
·
|
Personal
care segment operating profit increased 19.7 percent as higher
sales
volumes, increased net selling prices and cost savings more than
offset
higher raw materials costs. In North America, the benefits of
higher sales volumes, increased net selling prices and cost savings
were
tempered by raw materials inflation and increased product improvement
costs.
|
·
|
Consumer
tissue segment operating profit declined 4.9 percent as higher
net selling
prices and increased sales volumes were more than offset by raw
materials
cost inflation and increased marketing and general expenses. In
North America, operating profit declined because higher sales
volumes,
increased net selling prices and cost savings were more than
offset by raw
materials cost inflation, primarily for pulp, increased costs
for product
improvements and increased marketing expenses. Operating profit
in Europe increased due to cost savings, favorable currency effects
and
lower distribution costs exceeding the impact of raw materials
cost
inflation. In the developing and emerging markets, operating
profit decreased as net selling price gains were more than offset
by
higher manufacturing and distribution
costs.
|
·
|
Operating
profit for K-C Professional & Other products increased 5.3 percent due
to cost savings, the higher sales volumes and net selling prices,
partially offset by raw materials cost
inflation.
|
·
|
Health
Care segment operating profit decreased 10.8 percent as higher
raw
materials cost inflation, primarily for nonwovens, unfavorable
currency
effects related to the Thai baht, the lower sales volumes and
higher
distribution and general expenses more than offset cost
savings.
|
Operating
Profit
|
2007
|
2006
|
||||
North
America
|
$
|
496.5
|
$
|
495.0
|
||
Outside
North America
|
237.5
|
183.2
|
||||
Other
income and (expense), net
|
.3
|
(1.6
|
)
|
|||
Corporate
& Other
|
(85.6
|
)
|
(132.5
|
)
|
||
Consolidated
|
$
|
648.7
|
$
|
544.1
|
·
|
Operating
profit in North America was even with last
year.
|
·
|
Operating
profit outside North America increased 29.6 percent primarily due
to
higher earnings for personal care in the developing and emerging
markets.
|
·
|
Nonoperating
expense of $47.5 million for the second quarter of 2007 is the
Corporation’s pretax loss associated with its ownership interest in the
synthetic fuel partnerships described in Note 5 to the Consolidated
Financial Statements.
|
·
|
Interest
expense decreased 5.8 percent primarily due to a higher amount
of interest
being capitalized for equipment construction combined with the
effect of a
lower average level of debt offset by higher interest
rates.
|
·
|
The
Corporation’s effective income tax rate was 20.0 percent in 2007 compared
with 26.8 percent in 2006. The decrease in 2007 was primarily
due to higher synthetic fuel
credits.
|
·
|
The
Corporation’s share of net income of equity affiliates was essentially the
same as in 2006 despite a slight decline in net income at Kimberly-Clark
de Mexico, S.A.B. de C.V. (“KCM”). Continued improvement in
results for KCM’s consumer business and a lower effective tax rate were
offset by the absence of earnings from pulp and paper operations
that were
sold in the fourth quarter of last
year.
|
Net
Sales
|
2007
|
2006
|
||||
Personal
Care
|
$
|
3,679.1
|
$
|
3,340.1
|
||
Consumer
Tissue
|
3,161.7
|
2,931.6
|
||||
K-C
Professional & Other
|
1,460.4
|
1,356.8
|
||||
Health
Care
|
599.4
|
618.3
|
||||
Corporate
& Other
|
17.0
|
16.7
|
||||
Intersegment
sales
|
(30.3
|
)
|
(34.2
|
)
|
||
Consolidated
|
$
|
8,887.3
|
$
|
8,229.3
|
Percent Change in Net Sales Versus Prior Year
|
|||||||||||||||
Changes Due To
|
|||||||||||||||
Total
|
Volume
|
Net
|
|||||||||||||
Change
|
Growth
|
Price
|
Currency
|
Other
|
|||||||||||
Consolidated
|
8.0
|
3
|
1
|
3
|
1
|
||||||||||
Personal
Care
|
10.1
|
7
|
-
|
3
|
-
|
||||||||||
Consumer
Tissue
|
7.8
|
1
|
3
|
3
|
1
|
||||||||||
K-C
Professional & Other
|
7.6
|
4
|
1
|
3
|
-
|
||||||||||
Health
Care
|
(3.1
|
)
|
(5
|
)
|
-
|
1
|
1
|
·
|
Personal
care net sales increased 10.1 percent. The increase was due to
higher sales volumes in each geographic region and favorable currency
effects primarily in Europe, Australia and
Brazil.
|
·
|
Consumer
tissue net sales increased 7.8 percent due to higher net selling
prices in
North America and the developing and emerging markets, and favorable
currency effects, principally in
Europe.
|
·
|
Net
sales of K-C Professional & Other products increased 7.6 percent
because of higher sales volumes in each of the major geographic
regions
and favorable currency effects, principally in
Europe.
|
·
|
Health
care net sales decreased 3.1 percent due to lower sales
volumes.
|
Net
Sales
|
2007
|
2006
|
||||
North
America
|
$
|
5,005.9
|
$
|
4,795.7
|
||
Outside
North America
|
4,196.5
|
3,710.7
|
||||
Intergeographic
sales
|
(315.1
|
)
|
(277.1
|
)
|
||
Consolidated
|
$
|
8,887.3
|
$
|
8,229.3
|
·
|
Net
sales in North America increased 4.4 percent primarily due to the
higher
sales volumes.
|
·
|
Net
sales outside North America increased 13.1 percent because of the
higher
personal care sales volumes, increased consumer tissue net selling
prices
and favorable currency effects, primarily in
Europe.
|
Operating
Profit
|
2007
|
2006
|
||||
Personal
Care
|
$
|
740.4
|
$
|
628.6
|
||
Consumer
Tissue
|
376.0
|
386.6
|
||||
K-C
Professional & Other
|
228.6
|
218.4
|
||||
Health
Care
|
107.6
|
109.6
|
||||
Other
income and (expense), net
|
(3.3
|
)
|
(21.8
|
)
|
||
Corporate
& Other
|
(184.5
|
)
|
(356.9
|
)
|
||
Consolidated
|
$
|
1,264.8
|
$
|
964.5
|
(Millions
of dollars)
|
2007
|
2006
|
||||
Other
income and (expense), net
|
$
|
9.3
|
$
|
(10.9
|
)
|
|
Corporate
& Other
|
(90.9
|
)
|
(287.1
|
)
|
Percentage Change in Operating Profit Versus Prior Year
|
|||||||||||||||||||||||||||
Changes Due To
|
|||||||||||||||||||||||||||
Raw
|
Energy and
|
||||||||||||||||||||||||||
Total
|
Net
|
Materials
|
Distribution
|
||||||||||||||||||||||||
Change
|
Volume
|
Price
|
Cost
|
Expense
|
Currency
|
Other
(a)
|
|||||||||||||||||||||
Consolidated
|
31.1
|
15
|
9
|
(16
|
)
|
(5
|
)
|
4
|
24
|
(b)
|
|||||||||||||||||
Personal
Care
|
17.8
|
17
|
-
|
(6
|
)
|
(2
|
)
|
2
|
7
|
||||||||||||||||||
Consumer
Tissue
|
(2.7
|
)
|
4
|
20
|
(19
|
)
|
(6
|
)
|
3
|
(5
|
)
|
||||||||||||||||
K-C
Professional &
Other
|
4.7
|
8
|
5
|
(17
|
)
|
(3
|
)
|
2
|
10
|
||||||||||||||||||
Health
Care
|
(1.8
|
)
|
6
|
-
|
(8
|
)
|
(7
|
)
|
5
|
2
|
·
|
Personal
care operating profit increased 17.8 percent due to the higher
sales
volumes in each of the geographic regions and cost savings, tempered
by
increased marketing and general
expenses.
|
·
|
Consumer
tissue segment operating profit decreased 2.7 percent as increased
net
selling prices and cost savings were more than offset by raw materials
cost inflation and higher distribution and marketing
expenses.
|
·
|
Operating
profit for K-C Professional & Other increased 4.7 percent because
higher sales volumes, increased net selling prices and cost savings
more
than offset raw materials cost
inflation.
|
·
|
Health
care segment operating profit declined 1.8 percent as cost savings
were
more than offset by raw materials cost inflation and increased
distribution costs.
|
·
|
Other
income and (expense), net for 2007 includes gains of $9.3 million on
properties disposed of as part of the strategic cost reduction
plan
compared with a loss on disposition of $10.9 million in
2006. Foreign currency transaction losses were approximately
$2 million lower in 2007 versus
2006.
|
Operating
Profit
|
2007
|
2006
|
||||
North
America
|
$
|
987.4
|
$
|
982.6
|
||
Outside
North America
|
465.2
|
360.6
|
||||
Other
income and (expense), net
|
(3.3
|
)
|
(21.8
|
)
|
||
Corporate
& Other
|
(184.5
|
)
|
(356.9
|
)
|
||
Consolidated
|
$
|
1,264.8
|
$
|
964.5
|
(Millions
of dollars)
|
2007
|
2006
|
||||
Other
income and (expense), net
|
$
|
9.3
|
$
|
(10.9
|
)
|
|
Corporate
& Other
|
(90.9
|
)
|
(287.1
|
)
|
·
|
Operating
profit in North America was essentially the same as the prior
year.
|
·
|
Operating
profit outside North America increased 29.0 percent with higher
earnings
in each of the major geographic
regions.
|
·
|
Nonoperating
expense of $75.1 million for the first six months of 2007 is the
Corporation’s pretax loss associated with its ownership interest in the
synthetic fuel partnerships described in Note 5 to the Consolidated
Financial Statements.
|
·
|
Interest
expense decreased 6.0 percent primarily due to a higher amount
of interest
being capitalized for equipment construction combined with the
effect of a
lower average level of debt offset by higher interest
rates.
|
·
|
The
Corporation’s effective income tax rate was 20.3 percent in 2007 compared
with 27.3 percent in 2006. The decrease in 2007 was primarily
due to higher synthetic fuel credits and favorable settlements
of tax
issues related to prior years.
|
·
|
The
Corporation’s share of net income of equity affiliates increased 7.2
percent primarily due to higher earnings at KCM. Continued
strong performance of KCM’s consumer business as well as a lower level of
currency transaction losses than in 2006 drove the increase, despite
the
absence of earnings from pulp and paper operations that were sold
in the
fourth quarter of last year.
|
·
|
Cash
provided by operations for the first six months of 2007 increased
by $57.3
million from 2006, reflecting higher cash earnings primarily offset
by an
increased investment in working capital compared with last
year. The change in working capital was mainly attributable to
payment of accrued liabilities.
|
·
|
Capital
spending for the first six months was $544 million compared with
$399
million in the prior year. As previously announced, capital
spending in 2007 is expected to total $900 million to $1
billion.
|
·
|
At
June 30, 2007, total debt and preferred securities was $4.4 billion,
essentially the same level as the end of 2006. See Note 10 to
the Consolidated Financial Statements for a description of certain
financing and investing activities occurring subsequent to June 30,
2007.
|
·
|
As
discussed in Note 2 to the Consolidated Financial Statements, the
Corporation adopted FIN 48 as of January 1, 2007 and recorded an
increase in income tax liabilities for uncertain tax benefits and
a
decrease in retained earnings of $34.2 million. As of
January 1, 2007, the Corporation had approximately $490 million
of unrecognized tax benefits that it is unable to reasonably determine
when such benefits will be settled.
|
·
|
During
the first six months of 2007, the Corporation repurchased approximately
4.3 million shares of its common stock at a cost of $300 million,
including 2.1 million shares repurchased during the second quarter
at a
cost of $150 million. Including the $2.0 billion accelerated
share repurchase program described in Note 10 to the Consolidated
Financial Statements, the Corporation’s new full year 2007 share
repurchase target is $2.8 billion, up from its original target
of $600 to
$800 million.
|
·
|
In
connection with the new long-term Notes described in Note 10 to
the
Consolidated Financial Statements, on July 24, 2007, Standard & Poor’s
lowered the Corporation’s senior unsecured debt rating to A+ with a
negative outlook and Moody’s Investor Services lowered its rating to A2
with a stable outlook. The Corporation’s commercial paper
rating was lowered by Standard & Poor’s from A1+ to A1 while it
remained unchanged at P1 by Moody’s Investor
Services.
|
·
|
Management
believes that the Corporation’s ability to generate cash from operations
and its capacity to issue short-term and long-term debt are adequate
to
fund working capital, capital spending, payment of dividends, repurchases
of common stock and other needs in the foreseeable
future.
|
Cumulative
|
Remaining
|
|||||||||||||
Number Of
|
Shares That
|
|||||||||||||
Period
|
Shares
Purchased (1)
|
Average Cost
|
Shares Purchased
|
May Be
|
||||||||||
(2007)
|
Per Share
|
Pursuant To The Plan
|
Repurchased
|
|||||||||||
April
1 to 30
|
675,000
|
$
|
70.51
|
19,678,000
|
30,322,000
|
|||||||||
May
1 to 31
|
735,000
|
71.18
|
20,413,000
|
29,587,000
|
||||||||||
June
1 to 30
|
726,000
|
69.04
|
21,139,000
|
28,861,000
|
(2)
|
|||||||||
Total
|
2,136,000
|
(1)
|
Share
repurchases were made pursuant to a share repurchase program authorized
by
the Corporation’s Board of Directors on September 15, 2005,
which allowed for the repurchase of 50 million shares in an amount
not to exceed $5.0 billion.
|
(2)
|
Prior
to implementation of the accelerated share repurchase program and
authorization of a new share repurchase program as discussed in
Note 10 to the Consolidated Financial
Statements.
|
|
(3)a
|
Amended
and Restated Certificate of Incorporation, dated April 26, 2007,
incorporated by reference to Exhibit No. (3)a of the Corporation’s
Quarterly Report on Form 10-Q for the quarter ended March 31,
2007.
|
|
(3)b
|
By-Laws,
as amended September 14, 2006, incorporated by reference to
Exhibit No. (3)b of the Corporation’s Current Report on
Form 8-K dated September 18,
2006.
|
|
(4)
|
Copies
of instruments defining the rights of holders of long-term debt
will be
furnished to the Securities and Exchange Commission on
request.
|
|
(31)a
|
Certification
of Chief Executive Officer required by Rule 13a-14(a) or
Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), filed
herewith.
|
|
(31)b
|
Certification
of Chief Financial Officer required by Rule 13a-14(a) or
Rule 15d-14(a) of the Exchange Act, filed
herewith.
|
|
(32)a
|
Certification
of Chief Executive Officer required by Rule 13a-14(b) or
Rule 15d-14(b) of the Exchange Act and Section 1350 of
Chapter 63 of Title 18 of the United States Code, furnished
herewith.
|
|
(32)b
|
Certification
of Chief Financial Officer required by Rule 13a-14(b) or
Rule 15d-14(b) of the Exchange Act and Section 1350 of
Chapter 63 of Title 18 of the United States Code, furnished
herewith.
|
|
SIGNATURES
|
By:
|
/s/
Mark A.
Buthman
|
Mark
A. Buthman
|
|
Senior
Vice President and
|
|
Chief
Financial Officer
|
|
(principal
financial officer)
|
By:
|
/s/
Randy J.
Vest
|
Randy
J. Vest
|
|
Vice
President and Controller
|
|
(principal
accounting officer)
|
|
(3)a
|
Amended
and Restated Certificate of Incorporation, dated April 26, 2007,
incorporated by reference to Exhibit No. (3)a of the Corporation’s
Quarterly Report on Form 10-Q for the quarter ended March 31,
2007.
|
(3)b
|
By-Laws,
as amended September 14, 2006, incorporated by reference to
Exhibit No. (3)b of the Corporation’s Current Report on
Form
8-K
dated September 18, 2006.
|
(4)
|
Copies
of instruments defining the rights of holders of long-term debt
will be
furnished to the Securities and Exchange Commission on
request.
|
(31)a
|
Certification
of Chief Executive Officer required by Rule 13a-14(a) or
Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), filed
herewith.
|
(31)b
|
Certification
of Chief Financial Officer required by Rule 13a-14(a) or
Rule 15d-14(a) of the Exchange Act, filed
herewith.
|
(32)a
|
Certification
of Chief Executive Officer required by Rule 13a-14(b) or
Rule 15d-14(b) of the Exchange Act and Section 1350 of
Chapter 63 of Title 18 of the United States Code, furnished
herewith.
|
(32)b
|
Certification
of Chief Financial Officer required by Rule 13a-14(b) or
Rule 15d-14(b) of the Exchange Act and Section 1350 of
Chapter 63 of Title 18 of the United States Code, furnished
herewith.
|